Revolution Medicines, Inc. (RVMD) Insider Trading -- Recent Executive & Director Transactions
16 insiders reported 257 Form 4 transactions for Revolution Medicines, Inc. (RVMD) over the past 18 months (most recent 2026-10-01). Recent activity: Sandler Alan B. (Chief Development Officer) Sell 2,200 shares, Sandler Alan B. (Chief Development Officer) Buy 6,000 shares, Sandler Alan B. (Chief Development Officer) Sell 1,609 shares, Sandler Alan B. (Chief Development Officer) Sell 1,000 shares, Sandler Alan B. (Chief Development Officer) Sell 1,199 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Sandler Alan B. | Chief Development Officer | Sell | 2,200 | $441,801 |
| 2026-10-01 | Sandler Alan B. | Chief Development Officer | Buy | 6,000 | $353,040 |
| 2026-10-01 | Sandler Alan B. | Chief Development Officer | Sell | 1,609 | $324,574 |
| 2026-10-01 | Sandler Alan B. | Chief Development Officer | Sell | 1,000 | $202,813 |
| 2026-10-01 | Sandler Alan B. | Chief Development Officer | Sell | 1,199 | $244,485 |
| 2026-10-01 | Sandler Alan B. | Chief Development Officer | Sell | 301 | $61,621 |
| 2026-09-29 | Cislini Jeff | SVP & General Counsel | Sell | 765 | $158,600 |
| 2026-09-28 | Mancini Anthony | Chief Global Commercialization Officer | Sell | 587 | $117,400 |
| 2026-09-28 | Mancini Anthony | Chief Global Commercialization Officer | Buy | 3,121 | $104,928 |
| 2026-09-28 | Mancini Anthony | Chief Global Commercialization Officer | Sell | 3,121 | $625,885 |
| 2026-09-24 | ANDERSON ELIZABETH M | Director | Sell | 2,648 | $512,227 |
| 2026-09-24 | ANDERSON ELIZABETH M | Director | Sell | 910 | $174,585 |
| 2026-09-24 | ANDERSON ELIZABETH M | Director | Buy | 5,070 | $5,678 |
| 2026-09-24 | ANDERSON ELIZABETH M | Director | Sell | 1,500 | $291,883 |
| 2026-09-24 | ANDERSON ELIZABETH M | Director | Sell | 100 | $19,515 |
| 2026-09-24 | ANDERSON ELIZABETH M | Director | Sell | 4,985 | $959,805 |
| 2026-09-22 | Mancini Anthony | Chief Global Commercialization Officer | Sell | 1,764 | $347,402 |
| 2026-09-18 | GOLDSMITH MARK A | President and Chief Executive Officer | Sell | 13,775 | $2.7M |
| 2026-09-18 | GOLDSMITH MARK A | President and Chief Executive Officer | Sell | 213 | $41,537 |
| 2026-09-18 | Horn Margaret A | Chief Operating Officer | Sell | 76 | $14,821 |
| 2026-09-18 | Anders Jack | Chief Financial Officer | Sell | 61 | $11,895 |
| 2026-09-18 | Sandler Alan B. | Chief Development Officer | Sell | 5 | $975 |
| 2026-09-18 | Cislini Jeff | SVP & General Counsel | Sell | 52 | $10,140 |
| 2026-09-18 | Mancini Anthony | Chief Global Commercialization Officer | Sell | 27 | $5,266 |
| 2026-09-18 | Kelsey Stephen Michael | Senior Advisor to the Chief Executive Officer | Sell | 85 | $16,576 |
Source: SEC Form 4 filings · as of 2026-10-01